Fenoxil

Quick links to important sections

Fenoxil

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenoxil

What is Fenoxil? Identity, Classification, and Purpose

Property Description
Active ingredient Nimesulide (INN)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Forms Tablet, granules for oral suspension, topical gel
General purpose Relieving pain, reducing inflammation, lowering fever
Origin Synthetic compound

What is Fenoxil's Active Ingredient and Drug Class?

Fenoxil is a prescription medicinal product defined by its sole active ingredient, Nimesulide, a synthetic compound chemically classified as a sulfonanilide derivative. It is formally categorized as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Fenoxil is typically marketed as a prescription-only medicine (Rx), positioning it for use under professional guidance. Nimesulide is noted for being a preferential Cyclooxygenase-2 (COX-2) inhibitor, a key feature that distinguishes it from older, non-selective NSAIDs. This classification establishes its core function as a targeted modulator of the body's inflammatory response.

What is the General Purpose of Fenoxil?

The general purpose of Fenoxil is to provide symptomatic relief by targeting the primary physical manifestations of inflammation and injury. Its pharmacological actions are threefold, acting as an analgesic (relieving pain), an antipyretic (reducing fever), and an anti-inflammatory agent (mitigating swelling and stiffness). Nimesulide is indicated for the management of acute physical discomfort. The benefit is often sought in scenarios requiring temporary mitigation of discomfort, such as muscle aches or fever accompanying mild illness.

What Forms is Fenoxil (Nimesulide) Available In?

The Nimesulide component is available under the name Fenoxil in several distinct pharmaceutical preparations. These commonly include tablets and granules for oral suspension for systemic treatment via the oral route of administration. It is also available as a topical gel for localized relief via application directly to the skin. This structural variety ensures the single-active ingredient can be delivered appropriately for either systemic or localized therapeutic effect, offering structural options based on the required site of action.

What side effects are possible with Fenoxil?

Possible Side Effects and Safety Information

The safety profile of Fenoxil, which contains Nimesulide, is defined by regulatory classifications of adverse reactions across several physiological systems. These classifications are used by government health authorities to communicate the medicine's risk profile.


Adverse Reaction Classifications

Adverse reactions are documented by frequency, ranging from commonly observed effects to very rare but serious events.

  • Common Reactions (up to 1 in 10 patients) often involve the Gastrointestinal disorders system, including diarrhea, nausea, and vomiting. Transient increases in liver enzymes are also classified as common.
  • Uncommon Reactions (up to 1 in 100 patients) may include cutaneous effects like pruritus or rash, as well as hypertension and edema.

Serious Adverse Reactions and Systemic Risks

The regulatory profile highlights the risk of serious adverse reactions, particularly those affecting the liver and the gastrointestinal tract.

  • Hepatobiliary disorders: Hepatitis, jaundice, and, very rarely, acute liver failure have been documented. Reports indicate that serious hepatic reactions can occur following relatively short exposure to the medication.
  • Gastrointestinal disorders: Risks include potentially life-threatening events such as gastrointestinal hemorrhage, ulceration, and perforation.
  • Dermatological risks: Very rare but severe skin reactions, including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are listed, with the highest risk noted during the first month of treatment.

Population and Use Constraints

The medicine is contraindicated in patients with any evidence of hepatic impairment or severe renal impairment. It is also contraindicated during the third trimester of pregnancy due to potential harm to the fetus. Use is restricted to the shortest possible duration necessary for symptom control, and immediate discontinuation is required if the patient develops fever or flu-like symptoms during treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

A suspected overdose of Fenoxil requires immediate medical attention. The official regulatory documentation for this medicine indicates that the initial symptoms of overdose are typically limited to nausea, vomiting, and epigastric pain, along with potential central nervous system effects such as drowsiness and lethargy.

However, overdose carries a risk of severe or life-threatening outcomes that necessitate emergency medical care. These documented severe manifestations include acute renal failure, respiratory depression, and coma. Anaphylactoid reactions are also listed as a possibility. When these severe symptoms occur, or are suspected, users must contact emergency services immediately.

Since no specific antidote is known for Fenoxil, regulatory guidance dictates that management must be based entirely on symptomatic and supportive care. This may involve interventions like the administration of activated charcoal if ingestion occurred within one to two hours of presentation. Due to the risk of systemic toxicity, hospital monitoring is required, focusing on assessing and stabilizing renal function, liver function, and the patient's overall acid-base status. Furthermore, official regulatory notes indicate that elderly patients and individuals with existing severe hepatic or renal impairment are at a heightened risk for severe complications following an overdose.

Therapeutic Uses of Fenoxil

What Fenoxil treats: Main Uses and Benefits

The primary role of Fenoxil, which contains Nimesulide, is to provide supportive symptomatic relief in conditions involving distressing physical manifestations. It is applied across domains where additional short-term symptomatic support is needed, helping to manage symptom clusters that may become intense or disruptive. The medication is considered relevant for easing symptoms related to specific, defined therapeutic applications.


Fenoxil is commonly used to address symptom clusters that include pain, swelling, and stiffness, which are symptoms that interfere with daily functioning. Specific therapeutic areas include symptomatic management of painful osteoarthritis, relief from the acute and recurrent manifestations of primary dysmenorrhoea (menstrual cramps), and assistance with discomfort following procedures such as dental surgery. Fenoxil is also relevant for easing symptoms related to systemic imbalance, such as fever.

Fenoxil provides support that helps ease the overall symptom burden during periods of heightened symptoms. It is commonly used when short-term symptomatic assistance is needed for acute or recurrent episodes and provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Pain and Inflammation Fenoxil is generally used for managing symptom clusters that include acute pain, localized inflammation, and associated musculoskeletal discomfort (sprains/strains).

Regulatory References

  1. European Medicines Agency (EMA) guidelines

Eligibility and Restrictions for Use

The eligibility profile for Fenoxil (Nimesulide) is strictly defined by regulatory authorities and centers on absolute prohibitions based on age, reproductive status, and pre-existing conditions.

Fenoxil is contraindicated and must not be used in children under 12 years of age. It is also contraindicated for women in the third trimester of pregnancy and throughout breastfeeding. Use is not recommended in women who are attempting to conceive or during the first and second trimesters of pregnancy.

Key health conditions that prohibit use include any degree of hepatic impairment or a history of prior hepatotoxic reactions to the drug. It is also contraindicated in patients with severe renal impairment (creatinine clearance less than 30 ml/min), severe heart failure, active gastric or duodenal ulcers, a history of gastrointestinal bleeding, or severe coagulation disorders.

Eligibility is generally restricted to adults and adolescents (12 to 18 years). Use is conditional, as the medicine is typically restricted to a second-line treatment option when other non-steroidal anti-inflammatory drugs have failed. Patients with mild to moderate renal impairment may be eligible without dosage adjustment.

What should I know about interactions with other medicines?

Fenoxil Interactions with other medicines and products


Category Official Regulatory Statement
High-Risk Combinations Co-administration is not recommended with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetylsalicylic acid, or similar anticoagulants due to the increased risk of bleeding complications. Exposure to other potentially hepatotoxic substances and alcohol abuse must be avoided during treatment.
Metabolic and Clearance Effects Fenoxil is a documented inhibitor of the CYP2C9 enzyme. Co-administration may increase the plasma concentrations of medicines that are substrates of CYP2C9. Caution is required if used less than 24 hours before or after methotrexate, as this may lead to an increase in methotrexate serum levels and associated toxicity.
Pharmacodynamic Interactions The medicine may reduce the diuretic and natriuretic response of Furosemide, necessitating caution in susceptible renal or cardiac patients. Due to potential for altered clearance, Lithium levels must be monitored closely if co-administered. The combination with Cyclosporines may increase the risk of nephrotoxicity.

The official regulatory profile for Fenoxil documents restrictions based on both pharmacodynamic reinforcement and pharmacokinetic interference. These constraints define the required separation from co-administered NSAIDs and anticoagulants to mitigate risk, and establish requirements for monitoring the plasma exposure of medicines like Lithium and Methotrexate due to altered clearance. The profile explicitly requires the avoidance of known hepatotoxic substances and alcohol, reflecting a primary regulatory concern.

Mechanism of Action

Fenoxil's action involves influencing the genetic control of fat and lipoprotein metabolism, resulting in modifications to circulating fat-carrying particles.

Activating the PPAR alpha Regulator

This mechanistic domain involves the drug's active metabolite binding to the Peroxisome proliferator-activated receptor alpha (PPAR alpha) in the cell nucleus, which functions as a key transcriptional regulator for numerous genes. Activation of this receptor modulates the activity of the liver's fat-handling pathways and contributes to the drug's physiological effects.


Enhancing Fat Breakdown and Clearance

The activation of PPAR alpha initiates or suppresses signaling sequences that modify the synthesis of key apolipoproteins and enhance fatty acid oxidation (beta-oxidation). This pathway modification accelerates the breakdown and removal (catabolism) of fat-rich particles from the bloodstream, resulting in alterations to the body's circulating fat profile.


Modulating Lipoprotein Component Balance

This domain encompasses the shift in apolipoprotein production, specifically decreasing the synthesis of inhibitory ApoC-III while increasing levels of ApoA-I/ApoA-II (components of HDL). This molecular change influences the targeted pathways, leading to the increased formation of high-density lipoprotein (HDL) particles and modifying the levels of low-density lipoproteins.

Dosage and Administration Information

How to Use Fenoxil

The administration protocols for Fenoxil (Nimesulide) establish a precise regimen focused on limiting systemic exposure. The primary route of administration for the 100 mg tablet and oral granules is oral (systemic), while a topical gel is available for localized application.


Administration Scope

Systemic use is restricted to a standard dose of 100 mg taken twice daily (bid), making the maximum daily dose 200 mg. This systemic medicine is taken after a meal to ensure proper administration.


Population-Specific Instructions

Specific dosage adjustments are generally not required for certain patient groups, provided the impairment falls within acceptable limits. For instance, older adults (the elderly), adolescents (12-18 years), and patients with mild to moderate renal impairment (creatinine clearance of 30-80 ml/min) require no reduction in the standard daily dosage.


Resulting Procedural Structure

Standard procedural conditions and limits:

  • The medicine is designated for use only as a second-line treatment.
  • The 100 mg oral dose is taken after a meal.
  • The dose is repeated twice daily.
  • Treatment duration is limited to the shortest possible period required for relief.
  • Treatment is discontinued upon reaching a maximum of 15 days.

This standardized usage protocol imposes time-bound and frequency constraints, defining Fenoxil's short-term role within a treatment strategy and specifying the conditions (after food) and limits (15 days maximum) under which the medicine is administered.

Recent Clinical Evidence

Recent Clinical Evidence / Overview of Studies

Efficacy in Episodic and Chronic Migraine

Research has explored whether the combination therapy may influence the frequency and severity of migraine attacks. Studies investigating the treatment for episodic migraine examined its influence on attack frequency over a three-month period. Studies have investigated the drug's influence on outcomes for acute pain episodes.

For participants with chronic migraine, researchers often utilized a low starting dose. Trials examined the potential for the combined therapy to affect migraine days in this population. One key study examined changes in headache days and reported observed findings over a six-month period. Findings were mixed on the correlation between participant age and the size of the observed outcome.


Comparisons and Tolerability

Studies comparing the combined approach to monotherapy have been conducted to examine potential differences in outcomes. Evidence explored whether differences in outcomes were observed when comparing combined administration of two agents to single agents. It is not yet clear whether one treatment approach has consistently demonstrated advantages over the other across all participant groups studied.

The evidence explores whether reported side effects may differ compared to older treatments. Studies in placebo-controlled trials included reporting on adverse events such as nausea, dizziness, and fatigue. Studies examined the relationship between participant adherence and observed findings.


Special Populations

Pediatric trials have been conducted to investigate the use of the drug in adolescents. These studies examined the tolerability profile and potential influence on attack frequency in participants aged 12 to 17. Evidence remains limited on the use of the combination in participants over the age of 65.

While studies explored its use, research has also examined its effects in populations, including those with cardiovascular conditions. The trials involved close monitoring for specific adverse events. The findings are insufficient to draw conclusions on suitability for all populations.

Key Studies & References

  1. Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial (DFN-15)
  2. Oral preventive medications for migraine in adults aged 18–65: a network meta-analysis
  3. NICE Clinical Guideline [CG150]: Headaches in over 12s: diagnosis and management
  4. Migraine-Cardiovascular-Disease (Review of cardiovascular risks associated with migraine treatments)

Frequently Asked Questions (FAQ)

Common questions about Fenoxil (FAQ)

Q: Do I need to change my diet while taking Fenoxil?

A: Official guidelines state that the medicine must be taken after a meal. This condition relates to the timing of administration concerning food intake. Beyond avoiding alcohol and certain strong drug interactions listed in the prescribing information, the regulatory documents generally do not mandate broad changes to a patient's diet.

Q: Can Fenoxil be taken with a common multivitamin?

A: Regulatory documents list specific, high-risk drug-drug interactions, particularly those affecting the body's metabolism pathways (like the CYP2C9 enzyme). Information on interactions with general multivitamins is typically not detailed in official prescribing guidance. Regulatory constraints emphasize providing a healthcare provider with a complete list of all concomitant supplements used.

Q: Is it normal to feel tired or dizzy when starting Fenoxil?

A: The documented safety profile for the active ingredient (Nimesulide) lists the potential for side effects that affect the nervous system. These may include the occurrence of dizziness and may cause sleepiness (somnolence) in some individuals. These are documented possibilities when taking the medicine.

Q: Can Fenoxil make you feel anxious or irritable?

A: The official safety profile categorizes adverse events that affect the nervous system and mental state. This includes the possibility of experiencing nervousness among the less common side effects reported by users. Documenting any unexpected changes in mood or behavior is generally recommended in patient monitoring.

Q: Can I take non-prescription pain relievers while on Fenoxil?

A: Official regulatory warnings strongly advise against taking this medicine with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) or with acetylsalicylic acid (Aspirin). This is because the combination is associated with an increased risk of bleeding complications.

Q: Can Fenoxil interact with herbal remedies like St. John's Wort?

A: The medicine is known to inhibit the CYP2C9 enzyme, a pathway used by the body to process many substances. Official documents generally require caution regarding the concomitant use of any substances, including herbal remedies, that may influence drug metabolism. This is to avoid potential increases in plasma concentration of other compounds.

Q: Can Fenoxil interact with common medications for heartburn or acid reflux?

A: Regulatory studies examining the use of this medicine alongside a common antacid preparation (containing aluminum and magnesium hydroxide) did not observe any clinically significant interactions. For specific use with other types of reflux medications, patients are generally directed to consult their healthcare provider.

Q: How long does it usually take to notice any effects from Fenoxil?

A: For the oral formulations (tablets or granules), pharmacological summaries generally describe the onset of action as taking approximately 2 to 3 hours. At this point, the medicine begins to show its anti-inflammatory and pain-relieving effects.

Q: Are there any long-term effects of taking Fenoxil for many years?

A: Regulatory documents restrict the treatment duration to the shortest possible period. The approved prescribing information indicates a maximum limit for the treatment course. This constraint is in place due to the known safety profile and the limited data supporting long-term, chronic use.

Q: If I miss a dose of Fenoxil, what is the generally recommended approach?

A: General patient information for twice-daily medicines typically describes taking the missed dose as soon as it is remembered. However, if the time for the next scheduled dose is only a few hours away, the missed dose should be skipped entirely. Regulatory guidance consistently describes that a double dose should not be taken to make up for a forgotten one.

Q: Is there a generic version of Fenoxil available?

A: The active ingredient in Fenoxil is Nimesulide. This compound has been available as both a branded and generic medicine in various global jurisdictions since its initial introduction, indicating wide availability under different trade names.

Q: Does Fenoxil affect blood pressure or heart rate?

A: The documented safety profile includes the cardiovascular system, listing hypertension (high blood pressure) as an uncommon adverse reaction (occurring in up to 1 in 100 patients). The effects on heart rate are not explicitly highlighted as a common adverse event in the regulatory documentation.

Q: Is Fenoxil safe for older adults (seniors)?

A: While regulatory documents state that dosage adjustments are generally not required for older adults with acceptable renal function, the product information advises caution in this population. This is due to a potential increase in the risk of undesired side effects in the elderly population.

Q: How often are people typically checked by their doctor while on Fenoxil?

A: Due to the documented potential for serious hepatic reactions (liver problems), the official profile highlights the need for patients to be monitored for signs and symptoms of liver injury. This monitoring is considered particularly important during the initial treatment period.

Q: Why do official documents sometimes list different side effects for Fenoxil?

A: Differences in official documents arise because the medicine has been subject to multiple, independent reviews by national and intergovernmental agencies across the world. This fragmented regulatory status means different jurisdictions, such as the European Medicines Agency (EMA), have implemented varying restrictions and specific labeling requirements.

Q: Is Fenoxil a new drug or has it been around for a long time?

A: The active ingredient, Nimesulide, has been available in some jurisdictions as a prescribed medicine since 1985, giving it a long history in certain global markets.

Q: Does Fenoxil affect sleep patterns?

A: The safety profile includes the possibility of the drug causing drowsiness (sleepiness) in some patients. Other specific sleep disturbances, such as insomnia, are not commonly listed as adverse reactions in the official prescribing information.

Q: What are the official restrictions for driving or operating machinery while taking Fenoxil?

A: Official warnings state that the drug may cause side effects such as dizziness or blurred vision. Patients are generally advised to not perform activities such as driving a vehicle or operating machinery if they experience these effects after taking the medicine.

Q: Why is Fenoxil used to treat more than one condition?

A: The medicine is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Its core pharmacological purpose is broad, as it acts as an analgesic (pain reliever), an antipyretic (fever reducer), and an anti-inflammatory agent. This set of actions makes it applicable to various conditions that involve these common symptoms.

Q: How is the safety of Fenoxil monitored after it has been approved?

A: Regulatory bodies continually monitor safety through post-marketing surveillance studies and the continuous reporting of adverse events by both healthcare professionals and patients. This data is used to periodically review and update the drug's safety profile and official use restrictions.

Q: Is it possible to be allergic to Fenoxil?

A: Official contraindications state that the medicine should not be taken if a person has a known hypersensitivity (allergy) to the active substance (Nimesulide), aspirin, or other NSAIDs. Like all medicines, an allergic reaction is a possibility, and very rare but severe skin reactions are also documented.

Q: What should I do if I experience a mild side effect from Fenoxil?

A: The official prescribing information highlights the need for immediate discontinuation if serious symptoms, such as those related to liver injury (e.g., fever or flu-like symptoms), develop. Regulatory documents do not provide specific instruction for mild effects; therefore, general patient self-monitoring is applicable.

Q: What is the difference between the brand name Fenoxil and its chemical name?

A: The brand name of the product is Fenoxil, and the generic name of the active ingredient is Nimesulide. For reference in scientific literature, the full systematic chemical name is N-(4-nitro-2-phenoxyphenyl)methanesulfonamide.

Q: Is it known if Fenoxil is processed mainly by the liver or the kidneys?

A: Pharmacokinetic data indicates that the drug is primarily cleared from the body by metabolic transformation in the liver, via the cytochrome P450 pathway. The elimination of unchanged drug in urine is described as negligible.

Q: Are there any known issues with Fenoxil and sun sensitivity?

A: For the topical gel formulation, official warnings state that application can make the treated skin area photosensitive (sensitive) to direct sunlight and other light sources. If using the topical form, exposure to these light sources should be avoided.

Q: Why are routine blood tests sometimes required when taking Fenoxil?

A: Routine monitoring is required because of the documented potential for transient liver enzyme elevation and the very rare but serious risk of acute liver failure. Blood tests are used to monitor liver function, which is a key measure in managing this major safety concern.

Q: Does Fenoxil contain any ingredients I should be aware of if I have a common allergy?

A: Regulatory documents require the manufacturer to list the complete product composition. Patients are advised to check the full list of ingredients (including inactive components like dyes, fillers, or binders) if they have a known allergy to ensure they are not exposed to a trigger.

Q: What is the shelf life of Fenoxil?

A: Regulatory rules require the manufacturer to study product stability and guarantee a minimum shelf life period. The specific expiry date must be indicated on the product label and is only guaranteed when the product is stored precisely as instructed.

How should Fenoxil be stored and disposed of?

How to Store and Dispose of Fenoxil (Nimesulide)

Storage Requirements

Fenoxil must be stored in a dry, cool, and well-ventilated place, protected from heat and direct sunlight. To ensure product integrity and identification, the medicine should be kept in its original container and the container must remain tightly closed. For safety, the product must be stored locked up and kept strictly out of the reach of children, according to regulatory guidelines.


Official Disposal Instructions

Unused or expired Fenoxil must be discarded according to official waste management protocols. The preferred method is to utilize a drug take-back program or mail-back service. The product must not be flushed down the toilet or poured down a sink to prevent environmental release. If take-back is unavailable, the medicine should be mixed with an undesirable substance (e.g., coffee grounds) and placed in a sealed bag before disposal in household trash, ensuring all personal information is removed from the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Fenoxil found in:

A-Z Index: